Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults
Clinical trial NCT01755689 · COMPLETED
Trial details
- NCT number
- NCT01755689
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-11
- Primary completion
- 2014-04-29
- Enrollment
- 1300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.